baber/WOPTO huggingface dataset:
Patent CA-2657175-A1 (CA)
Inventor: COOK JOHN H
IPC: E04H17/14
Filed: 2009-03-05
Abstract: A molded plastic fence having a unitary front fence section and a unitary rear fence section is provided. The unitary front fence section and the unitary rear fence section are coupled together to form a fence without visible molding artifacts. To emulate a traditional wooden fence, the fence sections preferably include various fence elements such as posts, slats and rails. The fence elements on each fence section typically have a planar member with an inner side and a raised edge extending from the inner side. The molding artifacts are disposed on the inner sides of the fence elements. The unitary front fence section and a unitary rear fence section are coupled with the raised edges engaging each other. In this configuration the molding artifacts are hidden from view and the fence elements appear as solid.
Patent CA-2660343-A1 (CA)
Title: Geospatial modeling system for separating foliage data from building data based upon loose and strict tolerance noise filtering operations and related methods
Inventor: RAHMES MARK
IPC: G06T17/05
Filed: 2007-08-09
Abstract: A geospatial modeling system (20) may include a geospatial model database (21) and a processor (22). The processor (22) may cooperate with the geospatial model database (21) for extracting ground data from foliage and building data (51), and performing a plurality of noise filtering operations on the foliage and building data comprising a first loose tolerance filtering to determine an inclusive estimate of building locations and a second strict tolerance filtering to reduce false building locations. The processor (22) may also cooperate with the geospatial model database (21) for performing at least one edge recovery operation to compensate for noisy building perimeters, and separating foliage data from the building data based upon the noise filtering operations and the at least one edge recovery operation.
Patent CA-2662364-A1 (CA)
Inventor: KITCHEN BARRY JAMES
IPC: A23L29/00
Filed: 2007-09-19
Abstract: An extract derived from sugar cane having GI or burn rate reducing characteristics wherein the extract comprises a mixture of one or more polyphenols, one or more carbohydrates, one or more minerals and one or more organic acids.
Patent CA-2664209-A1 (CA)
Inventor: AUYOUNG DAVID K Y
IPC: F27B9/24
Filed: 2006-01-18
Abstract: A thermal processing chamber having an endless conveyor belt providing a level surface for placement of products for thermal processing in the chamber. Thermal processing is completed through a combination of convection from impingement by a stream of thermally charged gas against the product and conduction between the conveyor belt and the product. The endless conveyor belt comprises a plurality of plates forming a flat, horizontal surface, each plate having a set of male and female linking elements, for linking with an adjacent plate so as to prevent misalignment of the plates.
Patent CA-2664947-A1 (CA)
Title: Coating process and article
Inventor: NIEDERST JEFFREY
IPC: C09D167/00
Filed: 2007-10-15
Abstract: A thermoplastic polymer advanceable by solid state polymerization is blended with at least one dissimilar thermoplastic polymer, or an organic or inorganic particulate filler. The blend is solid state polymerized to provide a modified polymer alloy or filled polymer blend having at least one physical or chemical property different from that of the blend before solid state polymerization. A substrate is coated with an adherent layer of the modified polymer alloy or filled polymer blend. The modified polymer alloy or filled polymer blend may also be coextruded with a layer of thermoplastic extrusion polymer having a melt viscosity similar to that of the modified polymer alloy or filled polymer blend and applied to a substrate to form an adherent coating.
Patent CA-2667119-A1 (CA)
Inventor: HOULE JEAN-FRANCOIS JF
IPC: C12Q1/68
Filed: 2007-10-18
Abstract: The invention relates to method, devices, and kits for measuring multiple analytes in a sample having a broad range of concentrations using optical d iffraction. Devices, methods, and kits useful for monitoring and diagnosing diabetes, cardiovascular disease, thyroid disease, hormone-related condition s, and sepsis are also described.
Patent CA-2668412-A1 (CA)
Inventor: HEGEMIER DARRIN G
IPC: C09J7/29
Filed: 2007-11-05
Abstract: A personalized adhesive cover for a consumer device includes multiple layers. In one implementation, an adhesive cover includes a top laminate layer adhered to a base layer that is adhered to a bottom adhesive layer. The base layer is treated to facilitate acceptance of a personalized design applied to the middle layer. The adhesive cover is contoured to partially or completely cover one or more sides of a consumer device. The cover can include one or more separate pieces, apertures and cutouts, for example, so that the cover does not interfere with the functions of a device.
Patent CA-2668958-A1 (CA)
Title: System and method for managing batch production
Inventor: AUGUSTO LEONARDO RANGEL
IPC: G06F9/44
Filed: 2009-06-12
Abstract: The illustrative embodiments described herein provide a computer implemented method, apparatus, and computer program product for managing a batch production system. In an illustrative embodiment, an application forecast is generated for a set of batch jobs in a critical path of a batch application. The application forecast comprises a sum of execution times for the batch jobs in the critical path. In response to detecting an abend from production data generated during the execution of the batch application, the abend is mapped against known abends in an abend database to identify a set of abend solutions. Thereafter, a notification is generated which comprises at least one of a status of the batch application and the set of abend solutions, wherein the status is generated based on the application forecast.
Patent CA-2669759-A1 (CA)
Inventor: BEERWERTH FRANK
IPC: A61B18/20
Filed: 2007-11-14
Abstract: The invention concerns a skin treatment device for irradiating a skin area with electromagnetic radiation. The skin treatment device has an elastic at least partially hollow ring structure (10) for leak-proof placement of the skin treatment device onto the skin (50). In another embodiment of the invention, the skin treatment device has a handle portion (2; 20, 21) including a radiation source (22) capable of emitting the electromagnetic radiation and a detachably mounted attachment (1) having the elastic at least partially hollow ring structure (10) for leak-proof placement of the skin treatment device onto the skin (50). As the device itself or the attachment (1) has an at least partially hollow ring structure, it can adapt nicely even to strongly curved skin topologies. The invention also concerns the attachment (1), the handle portion (2; 20, 21), and a kit comprising the handle portion (2; 20, 21) and at least an attachment (1).
Patent CA-2671981-A1 (CA)
Title: Dc power system
Inventor: KRAUS RUDY
IPC: H02J9/00
Filed: 2007-12-07
Abstract: There is provided a system that includes a power feed that distributes a direct current (DC) voltage in a building. The DC voltage is in a range of about 300 - 600 volts DC. The system also includes a motor, and a motor drive. The motor drive receives the DC voltage via the power feed, and from the DC voltage, derives an output that drives the motor.
Patent CA-2675387-A1 (CA)
Title: Dynamic stabilization member with molded connection
Inventor: JACKSON ROGER P
IPC: A61B17/70
Filed: 2008-01-18
Abstract: A dynamic fixation medical implant having at least two bone anchors includes a longitudinal connecting member assembly having at least one transition portion and cooperating outer sleeve, both the transition portion and sleeve being disposed between the two bone anchors. The transition portion includes a rigid length or rod having apertures therein and a molded plastic length that extends through the apertures, thus attaching the plastic length to the rigid length. The sleeve surrounds the transition portion and extends between the pair of bone anchors, the sleeve being compressible in a longitudinal direction between the bone anchors.
Patent CA-2676758-A1 (CA)
Inventor: SLACK MAURICE W
IPC: E21B19/06
Filed: 2006-05-03
Abstract: A gripping tool includes a body assembly and gripping assembly with a grip surface adapted to move from a retracted position to an engaged position to radially engage a work piece in response to relative axial displacement. A linkage is provided to act between the body assembly and the gripping assembly which, upon relative rotation in at least one direction, of the body relative to the grip surface results in relative axial displacement of the grip surface to activate the gripping elements. This tool was developed for use on drilling and service rigs having top drives, and supports rapid engagement and release, hoisting, pushing, and rotating.
Patent CA-2683681-A1 (CA)
Title: Analogues d'alpha-galactosyl ceramide et leur utilisation en immunotherapies
Inventor: WONG CHI-HUEY
IPC: A61K8/42
Filed: 2008-04-14
Abstract: L'invention concerne des analogues d'alpha-galactosyl céramide (a-GalCer), et leur utilisation en immunothérapies. Dans un aspect, un procédé d'activation d'une réponse de cytokine chez un sujet comprend l'administration d'une quantité efficace d'un composé à un sujet qui sujet a un système immunitaire adaptatif comprenant une population de cellules qui comprend au moins un lymphocyte et au moins une cellule présentant un antigène. Le composé est représenté par la structure de formule (1) dans laquelle n vaut 0 à 25; X est choisi parmi O et S; R1 est choisi parmi H, CH3 et un phényle, où le phényle est facultativement substitué par H, OH, OCH3, F, CF3, un phényle, un phényl-F, un alkyle en C1-C6 ou un alkyle ramifié en C2-C6; R2 est choisi parmi OH et H; R3 est choisi parmi un alkyle en C1-C15 et un phényle, où le phényle est facultativement substitué par H, OH, OCH3, F, CF3, un phényle, un alkyle en C1-C6 ou un alkyle ramifié en C2-C6 ; R4 est choisi parmi OH, OSO3H, OSO3Na et OSO3K; et R5 est choisi parmi CH2OH et CO2H; ou un sel pharmaceutiquement acceptable de ceux-ci. Le procédé susmentionné comprend aussi d'une part la formation d'un complexe entre le composé et la cellule présentant un antigène, la formation du complexe entraînant l'activation d'un récepteur sur le lymphocyte et, d'autre part, l'activation du lymphocyte pour produire la réponse de cytokine.
Patent CA-2685884-A1 (CA)
Inventor: XU XIAOCHUN
IPC: C10G3/00
Filed: 2008-07-14
Abstract: Methods for producing C10-C30 hydrocarbons from fatty materials, such as triglyceride compounds, are provided. Hydrocarbon compounds, particularly th ose boiling in the temperature range of between about 80°F to about 1000°F, are produced by contacting a fatty material with at least one catalyst compr ising cobalt and molybdenum on a zeolite support under hydrotreating conditi ons. Additional hydrotreating catalysts may also be used to further improve the properties of the hydrocarbon product.
Patent CA-2686807-A1 (CA)
Inventor: BOBIER JOSEPH A
IPC: H04L12/43
Filed: 2008-04-28
Abstract: This invention addresses the need to transport high bit-rate data to multiple users, or between users, over wired and wireless means. Specifically, this disclosure describes a new method of enabling communication from mobile phone to mobile phone when no network services are available as long as radio contact between the mobile handsets is possible by reserving un-assigned timeslots in the medium access control protocol super frame structure.
Patent CA-2691446-A1 (CA)
Inventor: YU CHONGXI
IPC: C07D487/08
Filed: 2007-06-04
Abstract: The novel positively charged pro-drugs of NSAIAs in the general formulas (1, 2a, 2b, 2c, or 2d) "Structure 1, 2a, 2b, 2c, or 2d" were designed and sy nthesized. The compounds of the general formulas (1, 2a, 2b, 2c, or 2d) "Str ucture 1, 2a, 2b, 2c, or 2d" indicated above can be prepared from metal salt s, organic base salts, or immobilized base salts of NSAIAs with suitable hal ide compounds. The positively charged amino groups in the pro-drugs in this invention largely increase the solubility of the drugs in water and will bon d to the negative charge on the phosphate head group of membrane. Thus, the local concentration of the outside of the membrane or skin will be very high and will facilitate the passage of these pro-drugs from a region of high co ncentration to a region of low concentration. This bonding will disturb the membrane a little bit and may make some room for the lipophilic portion of t he pro-drug. When the molecules of membrane move, the membrane may "crack" a little bit due to the bonding of the pro-drug. This will let the pro- drug insert into the membrane. At pH 7.4, only about 99% of the amino group is pr otonated. W hen the amino group is not protonated, the bonding between the a mino group of the pro-drug and the phosphate head group of the membrane will disassociate, and the pro-drugwill enter the membrane completely. When the amino group of the pro-drug flips to the other side of the membrane and thus becomes protonated, then the pro-drug is pulled into the cytosol, a semi- l iquid concentrated aqueous solution or suspension. These pro-drugs can be us ed for treating and preventing diabetes (type I or/and type II), abnormal bl ood glucose and lipid levels, stroke, heart attack, and other heart and vasc ular diseases Alzheimer's diseases, Parkinson's diseases and other neurodege nerative diseases, psoriasis, discoid lupus erythematosus, systemic lupus er ythematosus (SLE), autoimmune hepatitis, multiple sclerosis (MS), and other autoimmune diseases, amyotrophic lateral sclerosis (ALS), oculopharyngeal mu scular dystrophy ( OPMD), and other muscle disorders, inflamed hemorrhoids, cryptitis, other inflammatory conditions of the anorectum, and pruritus ani, prostatitis, prostatocystitis, varicose veins, autoimmune liver inflammatio n, autoimmune kidney inflammation, vein inflammation and other inflammations , skin cancers, breast cancer, colon-rectum cancer, oral cancer, and other c ancers, scars, abnormal vascular skin lesions, birthmarks, moles (nevi), ski n tags, aging spots (liver spots), and other skin disorders. These pro-drugs can be administered transdermally without the help of skin penetration enha ncers.
Patent CA-2692225-A1 (CA)
Title: Unknown
Inventor: HARPER KENNETH E
IPC: E04B1/18
Filed: 2010-03-04
Abstract: This is an abstract of the Trinity Post and Panel Inc. ("Trinity") design for an integrated log post & beam with insulated polyurethane panel construction system for shells of residential homes and buildings.   While some manufacturers utilize insulated panels for construction purposes, most use Expanded Polystyrene foam with either conventional 2 x 6 construction or lumber post and beam construction neither of which compare to the Trinity system of integrating logs with polyurethane panels.   An industry leading 3D design software is used to design each home. Each house is converted into appropriate log and panel components, which are individually drawn and sent to the manufacturing facility. Here the Trinity home utilizes polyurethane spray foam pressed between 2 pieces of 8' x 24' Oriented Strand Board to form wall panels 4'/2" thick or roof panels 6%" thick. These panels along with windows, doors and other openings are cut to size on a computer controlled CNC machine.
Patent CA-2693139-A1 (CA)
Inventor: NISHTALA VASU
IPC: A61M27/00
Filed: 2008-07-16
Abstract: A urinary catheter (30, 100) for indwelling introduction into a patient's urethra. The catheter includes an elongated flexible body portion (12) formed of a polymer. The elongated flexible body portion (12) includes a flexible introducing member.  The flexible introducing member (32) has a longitudinal bore. The bore can slideably position the introducing member (32) along the flexible body portion. A flexible polymeric sleeve (40) is affixed to the flexible introducing member. The flexible polymeric sleeve (40) can cover a substantial portion of the flexible body portion (12).  The method and apparatus can minimize the likelihood of infection by proving a sterile sleeve barrier on the catheter.
Patent CA-2693381-A1 (CA)
Inventor: KOENS ANTONIUS DOROTHEUS
IPC: B09B3/00
Filed: 2008-07-18
Abstract: The invention relates to a device and a method for the in situ processing of waste, in particular for cleaning up a waste disposal site. The device comprises a sorting device with a set of processing devices connected downstream of said device. This set of processing devices comprises a fermenting device, a fluidized bed gasifier, and a pyrolysis device. Furthermore, the assembly comprises a control device for controlling and measuring the various material flows.
Patent CA-2696279-A1 (CA)
Inventor: PEROTTINO PADDY
IPC: H01P1/161
Filed: 2008-09-05
Abstract: The present invention relates to a very broadband multiband transmission-reception coupler-separator of OMT (OrthoMode Transducer) type for RF frequency telecommunications antennas. This coupler comprises a port (P1) for propagating all the frequencies, a body and a port (P2) for propagating the high frequency bands, these three parts being coaxial, and broadband coupling slots (24A) for propagating the low frequency bands cut in the body and each associated with a waveguide, and it is characterized in that its body (24) joining the two ports exhibits a shape of revolution whose profile evolves according to a multi-polynomial law, constantly decreasing from the port of larger cross section (P1) to the port of smaller cross section (P2). This coupler can operate so as to couple and separate very wide passbands (the overall use of this coupler-separator being greater than one octave), two or four broadband coupling slots are necessary for propagating linear polarizations as well as circular polarizations after recombination.
Patent CA-2696437-A1 (CA)
Inventor: WAKITA TAKAJI
IPC: C12N15/09
Filed: 2008-07-11
Abstract: This invention relates to a nucleic acid comprising a nucleic acid sequence encoding an epitope tag peptide in the hypervariable region 1 of the E2 protein of naturally occurring or chimeric hepatitis C virus (HCV) genome, an epitope-tagged HCV  particle encoded by such nucleic acid, and a method for purifying the HCV  particles at a high purity in a simple manner with the use of an anti-epitope tag antibody-immobilized support.
Patent CA-2698911-A1 (CA)
Title: A personalized media server in a service provider network
Inventor: PODER JIM
IPC: H04L12/16
Filed: 2010-04-06
Abstract: Apparatuses and methods support a media server that is hosted in a service provider's network so that media content can be stored from or rendered to a Digital Living Network Alliance (DLNA) network. Media content may be stored directly by accessing the media server or by downloading the media content to the media server. A tunnel is established between an endpoint in the DLNA network through the service provider infrastructure to the media server. Subsequently, a session may be established between a DLNA device to the media server through the tunnel using a virtual address, where the media server is addressable as a virtual device within the DLNA network so that the virtual address is part of an address space of the DLNA network. The media server may support a plurality of DLNA networks, in which a tunnel is established to the media service for each DLNA network.
Patent CA-2706088-A1 (CA)
Inventor: KOTECHA LALIT RATILAL
IPC: H04L12/28
Filed: 2008-11-19
Abstract: A communications system for providing a user's mobile station (MS) with an Internet Protocol (IP) connectivity, has an IP network gateway for allocating an IP address to the MS to enable it to access an IP network. First and second base stations are respectively configured to support communications of the MS over first and second radio access networks using different radio access technologies. A first access gateway provides an interface between the IP network gateway and the first radio access network, whereas a second access gateway provides an interface between the IP network gateway and the second radio access network. A  handover interface is provided between the first access gateway and the second access gateway for enabling the MS to switch between the first and second radio access networks with minimum latency.
Patent CA-2708023-A1 (CA)
Title: Hydrogel cohesif monophasique biodegradable
Inventor: PIRON ESTELLE MARIE
IPC: A61L27/26
Filed: 2008-12-08
Abstract: Hydrogel cohésif monophasique biodégradable caractérisé en ce qu'il est constitué d'un mélange homogène de x po-lymères, identiques ou différents, réticulés préalablement à leur interpénétration par mélange sous forme d'hydrogel monophasique, lesdits polymères réticulés étant insolubles dans l'eau et miscibles entre eux, et x étant compris entre 2 et 5. Dans un mode de réalisa-tion, l'hydrogel selon l'invention est caractérisé en ce que les x polymères présentent des taux de réticulation identiques ou différents, au moins l'un des x polymères présentant un taux de réticulation x1 et au moins un des x polymères présentant un taux de réticulation x2, x1 étant supérieur ou égal à x2. L'invention concerne également le procédé  d'obtention d'un hydrogel selon l'invention et ses utilisations, par exemple pour la formulation d'une composition de viscosupplémentation ou d'une composition pour le comblement des rides.
Patent CA-2708960-A1 (CA)
Title: Flame resistant fabrics having improved resistance to surface abrasion or pilling and methods for making them
Inventor: TRUESDALE REMBERT JOSEPH III
IPC: D03D15/12
Filed: 2009-01-05
Abstract: Flame resistant fabrics and garments that have improved resistance to pilling and/or abrasion are disclosed. The fabrics, the fibers or yarns that make up the fabrics, or garments made from the fabrics are treated with a finish composition that is applied to the fibers, yarns, fabrics, or garments and then cured. The finish composition increases the resistance to pilling and/or abrasion of the fibers, yarns, fabrics, or garments. The finish composition includes a polymeric abrasion resistance aid, an alkylfluoropolymer, a polyethylene, and a wetting agent.
Patent CA-2709127-A1 (CA)
Inventor: STUBENRAUCH KAY-GUNNAR
IPC: G01N33/576
Filed: 2008-12-12
Abstract: The current invention comprises a method for determining of an antibody against a drug antibody in a sample using an immunoassay comprising a capture drug antibody and a tracer drug antibody, wherein the method comprises providing i) a capture drug antibody, which is the drug antibody conjugated to a solid phase, ii) a tracer drug antibody, which is the drug antibody conjugated to a detectable label, contacting the capture drug antibody separately with i) the sample, ii) the sample, to which the drug antibody in monomeric form has been added, iii) the sample, to which the drug antibody in oligomeric form has been added, and determining an antibody against the drug antibody in the sample by a positive immunoassay in i) and a negative immunoassay in ii) and iii).